Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
John C Araujo,1 Geralyn C Trudel,2 Prashni Paliwal3 1Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Bristol-Myers Squibb, Montreal, Quebec, Canada; 3Bristol-Myers Squibb, Wallingford, CT, USA Abstract:...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-03-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/long-term-use-of-dasatinib-in-patients-with-metastatic-castration-resi-a12424 |